Global Excipients for Oral Solid Dosage Forms Market Outlook, 2031

The global excipients for oral solid dosage forms market is fundamentally shaped by the growing complexity of modern pharmaceutical formulations, where inactive ingredients are no longer just supportive components but critical enablers of drug performance. Excipients are used in tablets, capsules, and other solid dosage formats to ensure that medicines maintain structural integrity, deliver accurate dosing, and achieve desired release characteristics within the body. These materials include a wide range of functional categories such as fillers for bulk, binders for cohesion, disintegrants for breakdown, and coatings for protection and controlled release. As oral solid dosage forms remain the most preferred method of drug administration due to convenience, stability, and cost-effectiveness, the role of excipients becomes increasingly important in ensuring consistent therapeutic outcomes. Pharmaceutical manufacturers rely on carefully selected excipient combinations to address formulation challenges such as poor compressibility, low solubility, and moisture sensitivity. Growing demand for high-potency and low-dose drugs is also increasing the need for highly functional excipients. Manufacturers are increasingly focusing on excipients that support better compressibility and flow properties during tablet production. There is also rising emphasis on compatibility between active ingredients and excipients to avoid formulation instability. In addition, advancements in drug development, particularly for complex and high-potency compounds, are placing greater emphasis on excipients that can enhance bioavailability and improve drug delivery efficiency. The shift toward more precise and performance-driven formulations is therefore transforming excipients from passive ingredients into essential components of pharmaceutical innovation. Increasing focus on patient-centric drug design is also encouraging the use of excipients that improve swallowability, taste masking, and dosage convenience.

The global excipients for oral solid dosage forms market is being shaped by a clear shift in how pharmaceutical companies approach formulation design, moving from conventional ingredient selection toward more performance-oriented and application-specific excipient use. Instead of relying on multiple single-function ingredients, manufacturers are increasingly adopting engineered excipients that can simplify formulation while maintaining stability and efficiency during production. This transition is closely linked to the rising complexity of drug molecules, where traditional formulation methods often fail to deliver consistent results. As a result, excipient suppliers are working more closely with pharmaceutical companies during early-stage drug development to co-develop formulations that can be scaled efficiently from laboratory to commercial production. This collaborative approach is reducing development timelines and improving formulation success rates. Increasing demand for high-speed manufacturing is also encouraging the use of excipients with better flow and compression properties. There is also a growing focus on minimizing formulation variability to ensure batch-to-batch consistency in large-scale production. The production ecosystem is becoming more interconnected, with formulation design, processing techniques, and manufacturing equipment being aligned to reduce trial-and-error cycles. At the same time, there is growing emphasis on improving manufacturability, particularly in high-speed tablet compression and capsule filling processes where excipient behavior directly impacts output quality. Increasing adoption of continuous manufacturing is also influencing excipient demand, as it requires materials that perform consistently under uninterrupted production conditions. Additionally, companies are focusing on developing excipients that support regulatory compliance while also offering better functionality, enabling smoother approval processes and faster market entry for new drugs.

Market Dynamics

Market Drivers
• Increasing Demand for Oral Solid Dosage Forms in Pharmaceutical Treatments: Oral solid dosage forms continue to dominate drug delivery due to ease of administration, stability, and cost advantages, driving consistent demand for excipients. Pharmaceutical companies are expanding production of tablets and capsules across therapeutic areas. This is increasing the need for reliable excipient solutions that ensure formulation performance and patient compliance.
• Growing Complexity of Drug Formulations and Need for Functional Excipients: Modern drugs often face challenges such as poor solubility and low bioavailability, requiring advanced excipients to improve formulation efficiency. Manufacturers are increasingly using multifunctional excipients to simplify production and enhance drug performance. This is driving innovation in excipient design and increasing their importance in pharmaceutical development.

Market Challenges
• Stringent Regulatory Requirements and Compliance Standards: Excipients used in pharmaceutical formulations must meet strict regulatory guidelines related to safety, quality, and consistency. Manufacturers are required to maintain detailed documentation and validation processes, which can increase operational complexity. This makes compliance a time-consuming and resource-intensive aspect of excipient production and usage.
• Variability in Raw Material Quality and Supply Constraints: Excipients are often derived from natural or chemical sources, making them susceptible to variations in quality and availability. Inconsistent raw material characteristics can impact formulation stability and production efficiency. This creates challenges for manufacturers in maintaining uniform product performance across batches. Fluctuations in raw material supply can also lead to production delays and increased procurement costs.



Market Trends
• Increasing Use of Multifunctional and Co-Processed Excipients: Pharmaceutical companies are increasingly adopting multifunctional excipients that can perform multiple roles within a single formulation. These excipients help reduce formulation complexity and improve manufacturing efficiency. This trend is supporting faster product development and more streamlined production processes.
• Rising Focus on Patient-Centric and Easy-to-Consume Formulations: There is growing emphasis on developing oral dosage forms that improve patient experience through better taste masking and ease of swallowing. Excipients are being designed to enhance sensory attributes and dosage convenience. This trend is encouraging innovation in excipient functionality and formulation design.

Regional Analysis

North America reflects a highly innovation-driven market where excipient development is closely tied to advanced drug formulation research and strong collaboration between pharmaceutical companies and material science providers. The region benefits from a mature pharmaceutical manufacturing base and early adoption of high-performance excipients designed for complex drug delivery systems. Europe presents a quality-focused landscape where regulatory expectations and formulation precision play a major role in shaping excipient usage, encouraging manufacturers to prioritize consistency, traceability, and compliance across production processes. Increasing focus on sustainable and safe pharmaceutical ingredients is also influencing excipient development across the region. Asia Pacific is emerging as a major production hub, supported by expanding pharmaceutical manufacturing capacity, cost-efficient production environments, and increasing participation in global generic drug supply chains across countries such as India and China. The region is also witnessing growing investments in excipient innovation and local sourcing capabilities. Rapid growth of contract manufacturing activities is further strengthening regional demand for high-quality excipients. South America is gradually developing with rising pharmaceutical demand and improving manufacturing infrastructure, particularly in urban markets where access to medicines is expanding. Meanwhile, the Middle East and Africa region is progressing steadily as healthcare systems strengthen and pharmaceutical production capabilities evolve, creating new opportunities for excipient adoption in regional drug manufacturing.

Key Developments

• In March 2025: BASF expanded its pharmaceutical excipients portfolio by introducing advanced functional excipients designed to improve solubility and drug stability in oral solid dosage formulations.
• In January 2025: Evonik Industries enhanced its excipient manufacturing capabilities by investing in specialized production facilities to support high-performance drug formulation requirements.
• In October 2024: Roquette launched a new range of co-processed excipients aimed at simplifying tablet formulation and improving manufacturing efficiency for pharmaceutical companies.